Symbol="CYTH"
AssetType="Common Stock"
Name="Cyclo Therapeutics Inc"
Description="Cyclo Therapeutics, Inc., a clinical-stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. The company is headquartered in Gainesville, Florida."
CIK="922247"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="INDUSTRIAL ORGANIC CHEMICALS"
Address="27317 NW 78 AVENUE, N/A, HIGH SPRINGS, FL, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="26483500"
EBITDA="-17675002"
PERatio="None"
PEGRatio="None"
BookValue="-0.044"
DividendPerShare="0"
DividendYield="0"
EPS="-1.64"
RevenuePerShareTTM="0.147"
ProfitMargin="0"
OperatingMarginTTM="-13.27"
ReturnOnAssetsTTM="-1.105"
ReturnOnEquityTTM="-2.805"
RevenueTTM="1333300"
GrossProfitTTM="1225800"
DilutedEPSTTM="-1.64"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.218"
AnalystTargetPrice="5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="8.65"
PriceToBookRatio="2.841"
EVToRevenue="6.57"
EVToEBITDA="-0.871"
Beta="-0.414"
num_52WeekHigh="2.75"
num_52WeekLow="0.67"
num_50DayMovingAverage="1.48"
num_200DayMovingAverage="1.469"
SharesOutstanding="15308400"
DividendDate="2020-12-09"
ExDividendDate="None"
symbol="CYTH"
open="1.67"
high="1.75"
low="1.67"
price="1.72"
volume="32605.00"
latest_trading_day="2023-07-11"
previous_close="1.62"
change="0.10"
change_percent="6.1728%"
aroon_positive_momentum_days="35"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="35"
Volume_recent_avg="132297"
Change_recent_avg="-0.01"
Delta_recent_avg="0.16"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="-1.49"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_30"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="35"
Aroon_momentum_negative="65"
image_negative_thumbnail_id_1="1157"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0191.jpeg"
image_negative_thumbnail_id_2="517"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0088.jpeg"
image_neutral_thumbnail_id_1="547"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0052.jpeg"
image_neutral_thumbnail_id_2="525"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0074.jpeg"
image_positive_thumbnail_id_1="668"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0040.jpeg"
image_positive_thumbnail_id_2="604"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0104.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1187"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
